Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reversible phosphorylation is the cell's most prevalent form of posttranslational modification, yet its role in the regulation of mitochondrial functions is poorly understood. We have discovered that a member of the dual-specific protein tyrosine phosphatase (DS-PTP) family,
PTPMT1
(PTP localized to the Mitochondrion 1) resides nearly exclusively in mitochondria.
PTPMT1
is targeted to the mitochondrion by an N-terminal signal sequence and is found anchored to the matrix face of the inner membrane. Knockdown of
PTPMT1
expression in the pancreatic insulinoma cell line INS-1 832/13 alters the mitochondrial phosphoprotein profile and markedly enhances both ATP production and insulin secretion. These data define
PTPMT1
as a potential drug target for the treatment of type II
diabetes
and strengthen the notion that mitochondria are an underappreciated site of signaling by reversible phosphorylation.
...
PMID:Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. 1606 Nov 74
Pagliarini et al (2005) recently identified a new mitochondrial specific protein tyrosine phosphatase,
PTPMT1
. This report comments on its consequences for mitochondrial function and on its potential to act as a therapeutic target in
diabetes
and cancer.
...
PMID:Firing up mitochondrial activities with PTPMT1. 1603 89